1. Home
  2. QNCX vs FT Comparison

QNCX vs FT Comparison

Compare QNCX & FT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$3.06

Market Cap

167.0M

Sector

Health Care

ML Signal

HOLD

Logo Franklin Universal Trust

FT

Franklin Universal Trust

HOLD

Current Price

$8.02

Market Cap

199.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
QNCX
FT
Founded
2012
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
167.0M
199.8M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
QNCX
FT
Price
$3.06
$8.02
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$7.67
N/A
AVG Volume (30 Days)
979.1K
63.0K
Earning Date
11-12-2025
01-01-0001
Dividend Yield
N/A
7.85%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$5.97
52 Week High
$4.55
$7.23

Technical Indicators

Market Signals
Indicator
QNCX
FT
Relative Strength Index (RSI) 47.31 47.12
Support Level $2.85 $8.04
Resistance Level $3.72 $8.05
Average True Range (ATR) 0.31 0.08
MACD 0.01 0.00
Stochastic Oscillator 41.38 38.46

Price Performance

Historical Comparison
QNCX
FT

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About FT Franklin Universal Trust

Franklin Universal Trust is a closed-end management investment company focused on providing high current income while preserving capital. Its secondary objective is to achieve income growth through dividend increases and capital appreciation. The fund invests in two asset classes: high-yield bonds and utility stocks. It applies fundamental research to build a diversified high-yield bond portfolio and targets utility companies with attractive dividend yields and a history of increasing dividends.

Share on Social Networks: